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When you cannot measure it, when you cannot express it in 
numbers-you have scarcely, in your thoughts. advanced 
to the stage of Science, whatever the mstkr may be. 
(William Thamrrna, Lard Kelvin) 
The g nt study. Beatunirtit and Vogel (I) i:: this issue of 
the Journal add their observations to a theme that has been 
played many times over the past decade (2). Visual estima- 
tions of the percent of coronary stenosis and absolute vessel 
diameter by angiography, the “measurements” from which 
most therapeutic decisions and many clinical trial end points 
are determined, are both imprecise and poorly reproducible. 
Why then go to the trouble of redemonstrating this unfortu- 
nate reality and further examining the relations among 
accuracy (in its broadest sense), observer experience, num- 
ber of observers and so forth? The authors emphasize one of 
many increasingly important reasons for their study: the 
need for reliable measurements to guide angioplasty deci- 
sions, specifically determination of balloon size. They could 
have as easily cited other reasons, some perhaps of greater 
importance. To paraphrase Lord Kelvin, you can’t know 
something until you can measure it correctly. 
Role of precise coronary stenosis me~u~~n~. A partial 
list of fundamental relations predicated on precise stenosis 
measurement includes I) prognosis in coronary disease; 2) 
the relation of stenosis and flow deficit; 3) the “need” for 
revascularization techniques; 4) the choice of balloon size in 
coronary angioplasty; 5) the outcome of coronary angio- 
plasty; 6) the identification of restenosis; 7) the relation 
between risk factors and disease severity; and 8) the pro- 
gression and regression of disease. 
Admittedly, even imprecise measurements of stenosis 
and absolute vessel diameter have been clinically and scien- 
tifically useful, from the pioneering observations on progno- 
sis made by Cleveland Clinic investigators 2 decades ago (3) 
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to the initial evaluation of developmental tools today 
(atherectomy and laser techniques, among others). 
research and development goals of the coming dec 
and will be more rigorous. The old methods no longe 
Consider, for example, that a new ~~armaco~ 
could reduce the magnitude of postangiop~asty reste~osis by 
one third. Would we recogni 
angiographic inter 
Heretofore, most assess 
been made with the unre 
of high quality. In realit 
nonetheless are used to 
graphic film can result from one or 
poor equipment and poor technique. Stenosis measurements 
are still made on arbitnrily selected frames with no regard 
for location in the cardiac contraction cycle or 
the nuwber of projections incorporated into t 
ment. These technical problems are solvable and the solu- 
tions are overdue. 
High levels of reproducibility and ~recisiom 
more recalcitrant problems but are not without 
solutions. Although imperfect, multiple on- an 
quantitative methods such as the one used in the present 
study and others (4) are available today and. as shown by 
Beauman and Vogel (I), are dramatically superior to the 
inte~retatio~ of a sin 
~o~c~~s~~~~. Although consensus and “panel” analyses 
of angiograms have been and are still employed for impor- 
tant clinical studies (5). notably investigations examining 
progression and regression of disease, quantitative methods 
can, should and will supercede them. For clinical use and on 
the spot decisions, particularly with reference to angioplasty 
options, consensus panels are impractical and therefore the 
use of reproducible quantitative systems should become the 
“tine” qua non. 
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